We’re pleased to share a new publication from CeMi researchers, recently published in the Journal of Tissue Engineering: “Mechanical regulation of mesenchymal stem cell osteogenesis, bone matrix homoeostasis, and skeletal pathology” Udipt R. Das, Hussain Jaffery, Penelope M. Tsimbouri and Matthew J. Dalby (2026) 👉 Read the paper: https://journals.sagepub.com/doi/10.1177/20417314261454194 The paper explores how mechanical forces—such ...
Over the weekend, the Centre for the Cellular Microenvironment (CeMi) brought science to life for young minds at the Glasgow Science Festival with our interactive activity: “Building Life: From Cells to Medicines.” Our activities were all about learning through play. Children (and plenty of adults!) got involved in: Building their own cells using play-doh Feeling ...
On Thursday 7 May 2026, the Centre for Human Specific Research hosted the launch of its Regional Scotland Community, welcoming researchers from across disciplines to explore the future of human‑specific, animal‑free research approaches. The morning programme opened with talks from Fiona ...
The Scottish Cell Biology Meeting (SCBM) will return to Glasgow on Friday 4 September 2026, bringing together postgraduate students and early‑career researchers from across Scotland for a friendly, inclusive day of science, networking, and discussion. This free one‑day conference, kindly sponsored by the British Society for Cell Biology (BSCB), is designed to provide a supportive ...
Dr Oana Dobre has been awarded a High Polymer Research Group (HPRG) Bursary to attend the 64th HPRG Meeting, entitled “Polymers for an increasingly challenging world”, taking place from 26–30 April 2026 in Cheshire, UK. The HPRG Meeting is a prestigious, invitation‑only conference that brings together leading academic researchers and industrial scientists to discuss cutting‑edge ...
Dr Carsten Schulte has been awarded a prestigious AMS Springboard Award, supporting the establishment and expansion of a new research programme focused on glioblastoma, the most common and aggressive primary brain tumour in adults. Glioblastoma currently has no cure, with a median survival time of just 12–18 months, underlining the urgent need for novel and ...
